特記事項（精製）ab78899 was affinity purified from rabbit antiserum by affinity chromatography using epitope specific phosphopeptide. The antibody against non phosphopeptide was removed by chromatography
using non phosphopeptide corresponding to the phosphorylation site.
機能Transcriptional coactivator for steroid receptors and nuclear receptors. Coactivator of the steroid binding domain (AF-2) but not of the modulating N-terminal domain (AF-1). Required with NCOA1 to control energy balance between white and brown adipose tissues.
関連疾患Note=Chromosomal aberrations involving NCOA2 may be a cause of acute myeloid leukemias. Inversion inv(8)(p11;q13) generates the KAT6A-NCOA2 oncogene, which consists of the N-terminal part of KAT6A and the C-terminal part of NCOA2/TIF2. KAT6A-NCOA2 binds to CREBBP and disrupts its function in transcription activation.
配列類似性Belongs to the SRC/p160 nuclear receptor coactivator family. Contains 1 bHLH (basic helix-loop-helix) domain. Contains 1 PAS (PER-ARNT-SIM) domain.
ドメインContains four Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. The LXXLL motifs are essential for the association with nuclear receptors and are, at least in part, functionally redundant. The LLXXLXXXL motif is involved in transcriptional coactivation and CREBBP/CBP binding. Contains 2 C-terminal transcription activation domains (AD1 and AD2) that can function independently.
翻訳後修飾Phosphorylated upon DNA damage, probably by ATM or ATR.
Class E basic helix-loop-helix protein 75 antibody
glucocorticoid receptor interacting protein 1 antibody
GRIP 1 antibody
NCoA 2 antibody
Nuclear receptor coactivator 2 antibody
Oncogene FGR antibody
SRC 2 antibody
Steroid receptor coactivator 2 antibody
TIF 2 antibody
Transcriptional intermediary factor 2 antibody
Anti-KAT13C / NCOA2 (phospho S736) antibody 画像
Western blot - KAT13C / NCOA2 (phospho S736) antibody (ab78899)
All lanes : Anti-KAT13C / NCOA2 (phospho S736) antibody (ab78899) at 1/500 dilution
Lane 1 : extracts from HeLa cells, treated
with TSA (400 nM, 24 hours) with no immunizing peptide Lane 2 : extracts from HeLa cells, treated
with TSA (400 nM, 24 hours) with immunizing peptide at 10 µg
Immunohistochemical analysis of KAT13C / NCOA2 in paraffin embedded human breast carcinoma tissue, using a 1/50 dilution of ab78899.
Left: untreated sample.
Right: sample treated with immunizing peptide.